Table 2.
Results of OMED, VAS, and neuropathic pain
| Intervention group (n = 30) | Control group (n = 30) | ||||||
|---|---|---|---|---|---|---|---|
|
OMED |
n |
Mean |
SD |
n |
Mean |
SD |
p-value |
| Baseline (t0) |
30 |
56.8 |
132.2 |
30 |
45.0 |
86.2 |
0.841 |
| RT completed (t1) |
30 |
43.8 |
88.7 |
30 |
50.7 |
88.7 |
0.452 |
| After 3 months (t2) |
22 |
30.2 |
59.1 |
21 |
62.7 |
84.6 |
0.091 |
| After 6 months (t3) |
18 |
20.8 |
46.9 |
18 |
76.7 |
103.6 |
0.018 |
|
Visual analog scale |
|
|
|
|
|
|
|
| Baseline (t0) |
30 |
48.2 |
20.5 |
30 |
51.3 |
26.9 |
0.393 |
| RT completed (t1) |
30 |
23.8 |
20.2 |
30 |
33.3 |
24.6 |
0.118 |
| After 3 months (t2) |
22 |
15.8 |
12.1 |
21 |
40.7 |
21.7 |
<0.001 |
| After 6 months (t3) |
18 |
16.7 |
14.8 |
18 |
50.3 |
22.8 |
<0.001 |
|
Neuropathic pain |
|
|
|
|
|
|
|
| Baseline (t0) |
30 |
0.2 |
0.4 |
30 |
0.2 |
0.4 |
0.749 |
| RT completed (t1) |
30 |
0.1 |
0.3 |
30 |
0.2 |
0.4 |
0.326 |
| After 3 months (t2) |
22 |
0.2 |
0.4 |
21 |
0.2 |
0.4 |
0.619 |
| After 6 months (t3) | 18 | 0.2 | 0.4 | 18 | 0.2 | 0.4 | 0.694 |
VAS was measured from 0 to 100 with 0 indicating no pain at all and 100 indicating worst possible pain.
Abbreviations: SD standard deviation, OMED oral morphine equivalent dose, VAS visual analog scale.